EMVision Medical Devices Statistics

Total Valuation

EMVision Medical Devices has a market cap or net worth of AUD 164.62 million. The enterprise value is 148.91 million.

Market Cap	164.62M
Enterprise Value	148.91M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

EMVision Medical Devices has 85.52 million shares outstanding. The number of shares has increased by 3.51% in one year.

Current Share Class	n/a
Shares Outstanding	85.52M
Shares Change (YoY)	+3.51%
Shares Change (QoQ)	+6.41%
Owned by Insiders (%)	20.41%
Owned by Institutions (%)	n/a
Float	56.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.80
PB Ratio	8.88
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-54.55
EV / Sales	13.27
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-24.38

Financial Position

The company has a current ratio of 6.40, with a Debt / Equity ratio of 0.16.

Current Ratio	6.40
Quick Ratio	6.30
Debt / Equity	0.16
Debt / EBITDA	n/a
Debt / FCF	-0.47
Interest Coverage	-19.51

Financial Efficiency

Return on equity (ROE) is -23.10% and return on invested capital (ROIC) is -9.54%.

Return on Equity (ROE)	-23.10%
Return on Assets (ROA)	-7.95%
Return on Capital (ROIC)	-9.54%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.63
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +18.41% in the last 52 weeks. The beta is 1.47, so EMVision Medical Devices's price volatility has been higher than the market average.

Beta (5Y)	1.47
52-Week Price Change	+18.41%
50-Day Moving Average	1.98
200-Day Moving Average	2.10
Relative Strength Index (RSI)	49.84
Average Volume (20 Days)	55,942

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, EMVision Medical Devices had revenue of AUD 11.22 million and -2.73 million in losses. Loss per share was -0.03.

Revenue	11.22M
Gross Profit	11.22M
Operating Income	-2.26M
Pretax Income	-2.03M
Net Income	-2.73M
EBITDA	-2.09M
EBIT	-2.26M
Loss Per Share	-0.03

Full Income Statement

Balance Sheet

The company has 18.61 million in cash and 2.90 million in debt, giving a net cash position of 15.71 million or 0.18 per share.

Cash & Cash Equivalents	18.61M
Total Debt	2.90M
Net Cash	15.71M
Net Cash Per Share	0.18
Equity (Book Value)	18.52M
Book Value Per Share	0.22
Working Capital	18.45M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -5.99 million and capital expenditures -115,103, giving a free cash flow of -6.11 million.

Operating Cash Flow	-5.99M
Capital Expenditures	-115,103
Free Cash Flow	-6.11M
FCF Per Share	-0.07

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -20.12% and -24.33%.

Gross Margin	100.00%
Operating Margin	-20.12%
Pretax Margin	-18.11%
Profit Margin	-24.33%
EBITDA Margin	-18.64%
EBIT Margin	-20.12%
FCF Margin	-54.43%

Dividends & Yields

EMVision Medical Devices does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.51%
Shareholder Yield	-3.51%
Earnings Yield	-1.76%
FCF Yield	-3.71%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

EMVision Medical Devices has an Altman Z-Score of 15.71.

Altman Z-Score	15.71
Piotroski F-Score	n/a